Inclusion Criteria:  Type 1 Myocardial Infarction (STEMI and NSTEMI)  Must have ≥ 2 of the following risk factors:  Age ≥ 65 Multi-vessel coronary artery disease (MVD) defined as ≥2 vessels or left main with a stenosis ≥50% Chronic kidney disease (CKD) defined as estimated glomerular filtration rate (GFR) ˂ 60 mL/min/1.73 m2 Diabetes mellitus (DM) Prior MI Must agree to participate in the study, to comply with all study procedures and follow-up contact Signed the informed consent form  Exclusion Criteria:  Requirement for treatment with full dose anticoagulant therapy (e.g., for atrial fibrillation) Participation in another trial in which the subject is known to receive or could receive anticoagulant or antiplatelet treatment as part of the trial intervention. Non-cardiovascular conditions that, in the judgment of the investigator, will limit survival to less than 2 years